学術雑誌論文 Contribution of α2A-adrenoceptor subtype to effect of dexmedetomidine and xylazine on spinal synaptic transmission of mice

Kobayashi, Takeshi  ,  Otsuguro, Ken-ichi  ,  Yamaguchi, Soichiro  ,  Ito, Shigeo

761pp.321 - 329 , 2015-08-15 , Elsevier
ISSN:0014-29991879-0712
NII書誌ID(NCID):AA00639687
内容記述
Alpha-2A adrenergic receptor (AR) subtype plays an important role in the analgesic effect of α2-AR agonists. Here, we examined the effects of α2-AR agonists, dexmedetomidine and xylazine, on spinal synaptic transmission in newborn C57BL/6J and α2A-AR mutant mice. Spinal reflex potentials, the monosynaptic reflex potential (MSR) and the slow ventral root potential (sVRP), were measured in isolated spinal cords. The compound action potential was measured in isolated lumbar nerve. Dexmedetomidine and xylazine suppressed both the MSR and sVRP in a concentration-dependent manner. In α2A-AR mutant mice, sVRP suppression by dexmedetomidine was greatly weakened, while that by xylazine (30-100μM) showed only slight attenuation. A high concentration (300μM) of xylazine completely suppressed the sVRP, even in α2A-AR mutant mice spinal cords, and also suppressed the compound action potential. MSR suppression by these α2-AR agonists had no difference between wild-type and α2A-AR mutant mice. These results suggest that sVRP suppression by dexmedetomidine and xylazine is mainly mediated by α2A-AR. In addition, a high concentration of xylazine inhibits conduction of the action potential, which is not mediated by α2A-AR. α2-AR is not responsible for the dexmedetomidine- and xylazine-mediated inhibition of the MSR. (C) 2015 Elsevier B.V. All rights reserved.
本文を読む

http://eprints.lib.hokudai.ac.jp/dspace/bitstream/2115/62681/1/Eur.J.Pharmacol.v761pdf.pdf

このアイテムのアクセス数:  回

その他の情報